Plant ID: NPO13784
Plant Latin Name: Dalbergia candenatensis
Taxonomy Genus: Dalbergia
Taxonomy Family: Fabaceae
NCBI TaxonomyDB:
1353443
Plant-of-the-World-Online:
490125-1
Australia; Bangladesh; Myanmar; Philippines; Indonesia; India; New Caledonia; Cambodia; Vietnam; China; Papua New Guinea; Vanuatu; Sri Lanka; Thailand; Fiji
TAAR1; | |
ACHE; | |
TOP1; | |
SMN1;SMN2; |
Cytochrome P450 Enzymes: | CYP2A6; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 2 | CYP2A6 | Cytochrome P450 2A6 | P11509 | CHEMBL5282 |
Hydrolase | ACHE | Acetylcholinesterase | P22303 | CHEMBL220 |
Isomerase | TOP1 | DNA topoisomerase I | P11387 | CHEMBL1781 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Small molecule receptor (family A GPCR) | TAAR1 | Trace amine-associated receptor 1 | Q96RJ0 | CHEMBL5857 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0006260; DNA replication | 6.708E-04 | 1.000E+00 | ACHE, TOP1 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 3.103E-03 | 1.000E+00 | CYP2A6 |
BP | GO:0032501; multicellular organismal process | GO:0002076; osteoblast development | 4.393E-03 | 1.000E+00 | ACHE |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 5.425E-03 | 1.000E+00 | CYP2A6 |
BP | GO:0008152; metabolic process | GO:0006796; phosphate-containing compound metabolic process | 8.963E-03 | 1.000E+00 | ACHE, TAAR1, TOP1 |
BP | GO:0008152; metabolic process | GO:0042136; neurotransmitter biosynthetic process | 1.185E-02 | 1.000E+00 | ACHE |
BP | GO:0008152; metabolic process | GO:0031623; receptor internalization | 1.416E-02 | 1.000E+00 | ACHE |
BP | GO:0032501; multicellular organismal process | GO:0032922; circadian regulation of gene expression | 1.416E-02 | 1.000E+00 | TOP1 |
BP | GO:0032501; multicellular organismal process | GO:0007416; synapse assembly | 1.799E-02 | 1.000E+00 | ACHE |
BP | GO:0008152; metabolic process | GO:0044255; cellular lipid metabolic process | 2.263E-02 | 1.000E+00 | ACHE, CYP2A6 |
BP | GO:0009987; cellular process | GO:0051262; protein tetramerization | 3.748E-02 | 1.000E+00 | ACHE |
BP | GO:0008152; metabolic process | GO:0018105; peptidyl-serine phosphorylation | 4.199E-02 | 1.000E+00 | TOP1 |
BP | GO:0050896; response to stimulus | GO:0009611; response to wounding | 4.549E-02 | 1.000E+00 | ACHE |
CC | GO:0044464; cell part | GO:0043204; perikaryon | 2.942E-02 | 1.000E+00 | TOP1 |
MF | GO:0003824; catalytic activity | GO:0003990; acetylcholinesterase activity | 5.177E-04 | 1.000E+00 | ACHE |
MF | GO:0003824; catalytic activity | GO:0008389; coumarin 7-hydroxylase activity | 5.177E-04 | 1.000E+00 | CYP2A6 |
MF | GO:0003824; catalytic activity | GO:0008392; arachidonic acid epoxygenase activity | 4.393E-03 | 1.000E+00 | CYP2A6 |
MF | GO:0003824; catalytic activity | GO:0016712; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 6.713E-03 | 1.000E+00 | CYP2A6 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 8.771E-03 | 1.000E+00 | CYP2A6 |
MF | GO:0005488; binding | GO:0043621; protein self-association | 1.390E-02 | 1.000E+00 | ACHE |
MF | GO:0005488; binding | GO:0001540; amyloid-beta binding | 1.544E-02 | 1.000E+00 | ACHE |
MF | GO:0005488; binding | GO:0001046; core promoter sequence-specific DNA binding | 2.866E-02 | 1.000E+00 | TOP1 |
MF | GO:0005488; binding | GO:0020037; heme binding | 3.270E-02 | 1.000E+00 | CYP2A6 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 4.074E-02 | 1.000E+00 | CYP2A6 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 1.250E-03 | 1.250E-02 | CYP2A6 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00983 | Drug metabolism - other enzymes | 1.145E-02 | 3.361E-02 | CYP2A6 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 1.615E-02 | 3.361E-02 | CYP2A6 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 1.713E-02 | 3.361E-02 | CYP2A6 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.812E-02 | 3.361E-02 | CYP2A6 |
09150 Organismal Systems | 09156 Nervous system | hsa04725 | Cholinergic synapse | 2.745E-02 | 3.431E-02 | ACHE |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 2.033E-02 | 3.361E-02 | CYP2A6 |
09100 Metabolism | 09103 Lipid metabolism | hsa00564 | Glycerophospholipid metabolism | 2.353E-02 | 3.361E-02 | ACHE |
09130 Environmental Information Processing | 09133 Signaling molecules and interaction | hsa04080 | Neuroactive ligand-receptor interaction | 6.736E-02 | 7.485E-02 | TAAR1 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 2.737E-01 | 2.737E-01 | CYP2A6 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|